Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared on LinkedIn:
“Join Dr. Peters Solange, patient advocate Merel Hennink, and me on Saturday September 6th at 1:30pm CEST as we discuss treating rare subtypes of lung cancer like NTRK fusion and HER2 mutant NSCLC at this WCLC25 symposium (Room 5). Hope to see you there!”
More posts featuring Lung Cancer.